Use of Mendelian randomization to better understand and treat sepsis

Abstract excerpt

Discovering novel therapies and defining the causal contribution of genes, proteins and lipids is challenging in sepsis, because sepsis is so heterogeneous; effective therapies in one patient may not be effective in another, explaining in part why sepsis trials have not been very successful.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hyperglycemia and glycemic control in critically ill and hospitalized patients
• Share to Metabolomics and Mass Spectrometry Studies
• Share to Sepsis Diagnosis and Treatment